Abbott Laboratories Share Price Lima
Stocks
ABTUS
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.54 USD | +5.78% |
|
+1.66% | -22.75% |
| Market Cap | 18TCr 16TCr 15TCr 14TCr 26TCr 17,38800Cr 26TCr 1,76500Cr 69TCr 8,62300Cr 68TCr 67TCr 29,79300Cr | P/E 2026 * |
29.6x | P/E 2027 * | 23x |
|---|---|---|---|---|---|
| Enterprise Value | 21TCr 18TCr 17TCr 15TCr 29TCr 19,62200Cr 29TCr 1,99100Cr 78TCr 9,73100Cr 77TCr 75TCr 33,62100Cr | EV / Sales 2026 * |
4.08x | EV / Sales 2027 * | 3.62x |
| Free-Float |
86.73% | Yield 2026 * |
2.48% | Yield 2027 * | 2.6% |
Last Transcript: Abbott Laboratories
| 1 day | +5.74% | ||
| 1 week | +1.66% | ||
| Current month | +15.34% | ||
| 1 month | +15.34% | ||
| 3 months | +11.55% | ||
| 6 months | -22.75% | ||
| Current year | -22.75% |
| 1 week | 101.66 |  | 101.66 |
| 1 month | 88.14 | | 101.66 |
| Current year | 82.56 | | 131.6 |
| 1 year | 82.56 | | 131.6 |
| 3 years | 82.56 | | 131.6 |
| 5 years | 82.56 | | 131.6 |
| 10 years | 82.56 | | 131.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.78% | +1.66% | - | - | 18TCr | |
| +3.27% | +5.59% | -5.46% | -1.47% | 11TCr | |
| +2.27% | +4.75% | +10.93% | +70.18% | 6.05TCr | |
| -4.21% | -6.07% | +22.50% | +49.01% | 5.05TCr | |
| +3.58% | +6.87% | -10.13% | -41.35% | 4.38TCr | |
| +1.66% | +3.30% | - | - | 3.36TCr | |
| +3.00% | +1.02% | -15.66% | -42.96% | 2.83TCr | |
| +2.41% | -5.92% | +31.12% | -7.52% | 2.33TCr | |
| +4.12% | +7.29% | +0.29% | -1.24% | 2.13TCr | |
| +1.78% | +0.95% | -11.55% | +0.68% | 2.03TCr | |
| Average | +2.33% | -1.01% | +2.75% | +3.17% | 4.33TCr | |
| Weighted average by Cap. | +3.12% | -0.24% | +2.31% | +9.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.03TCr 4.41TCr 4.11TCr 3.78TCr 7.09TCr 4,80400Cr 7.21TCr 49TCr 19TCr 2,38300Cr 19TCr 18TCr 8,23200Cr | 5.46TCr 4.79TCr 4.46TCr 4.11TCr 7.7TCr 5,21900Cr 7.83TCr 53TCr 21TCr 2,58800Cr 21TCr 20TCr 8,94300Cr |
| Net income | 631.95Cr 554.6Cr 516.45Cr 475.01Cr 890.44Cr 60TCr 905.71Cr 6.13TCr 2.4TCr 30TCr 2.37TCr 2.32TCr 1,03400Cr | 794.45Cr 697.21Cr 649.25Cr 597.15Cr 1.12TCr 76TCr 1.14TCr 7.7TCr 3.01TCr 38TCr 2.98TCr 2.92TCr 1,30000Cr |
| Net Debt | 2.34TCr 2.05TCr 1.91TCr 1.76TCr 3.29TCr 2,23400Cr 3.35TCr 23TCr 8.87TCr 1,10800Cr 8.78TCr 8.59TCr 3,82700Cr | 1.57TCr 1.38TCr 1.29TCr 1.18TCr 2.22TCr 1,50400Cr 2.26TCr 15TCr 5.97TCr 75TCr 5.91TCr 5.78TCr 2,57700Cr |
| Date | Price | Change |
|---|---|---|
| 24/26/24 | $101.66 | 0.00% |
| 27/26/27 | $101.66 | 0.00% |
| 24/26/24 | $101.66 | 0.00% |
| 22/26/22 | $101.66 | 0.00% |
| 21/26/21 | $101.66 | +1.66% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABTUS Stock
Select your edition
All financial news and data tailored to specific country editions
